跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BUPRENORPHINE SANDOZ buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Approved
STANDARD
BUPRENORPHINE SANDOZ buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2457b53d5d3a0a0e
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
2457b53d5d3a0a0e
Product Name
BUPRENORPHINE SANDOZ buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Artg Id
269676
Artg Name
BUPRENORPHINE SANDOZ buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2017-06-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d3c7a4f47fd855b792004a4ea05876ab.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/bb2c75ef4397d2f0782f421cdd2b115d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2457b53d5d3a0a0e
Type
Standard
Back to TGA Approvals
BUPRENORPHINE SANDOZ buprenorphine 15 micrograms/hour transdermal drug delivery system sachet - TGA Drug Approval Details
